# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k151348   
B. Purpose for Submission: New device   
C. Measurand: Propoxyphene, Nortriptyline and EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine)   
D. Type of Test: Qualitative immunochromatographic assay   
E. Applicant: Healgen Scientific, LLC.   
F. Proprietary and Established Names: Healgen Propoxyphene Test, Healgen Nortriptyline Test, Healgen EDDP (Methadone Metabolite) Test

# G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>Product Code</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>JXN</td><td rowspan=1 colspan=1>Class I</td><td rowspan=1 colspan=1>21 CFR 862.3700, Propoxyphene test system</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>DJR</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3620, Methadone test system</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>LFG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR, 862.3910 Tricyclic antidepressantdrugs Test System</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr></table>

# H. Intended Use:

1. Intended use(s): Refer to Indications for Use below

Healgen Propoxyphene Test is an immunochromatographic assay for the qualitative determination of Propoxyphene in human urine at a Cut-Off concentration of $3 0 0 ~ \mathrm { { n g / m L } }$ . The test is available in a Strip format, a Cassette format, a Dip Card format and a Cup format.

The test may yield preliminary positive results even when the prescription drug Propoxyphene is ingested, at prescribed doses; it is not intended to distinguish between prescription use or abuse of this drug. There is no uniformly recognized cutoff concentration level for Propoxyphene in urine. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive. For in vitro diagnostic use only. It is intended for prescription and for over-the-counter use.

Healgen Nortriptyline Test is an immunochromatographic assay for the qualitative determination of Nortriptyline in human urine at a Cut-Off concentration of $1 0 0 0 ~ \mathrm { { n g / m L } }$ . The test is available in a Strip format, a Cassette format, a Dip Card format and a Cup format.

The test may yield preliminary positive results even when the prescription drug Nortriptyline is ingested, at prescribed doses; it is not intended to distinguish between prescription use or abuse of this drug. There is no uniformly recognized cutoff concentration level for Nortriptyline in urine. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive. For in vitro diagnostic use only. It is intended for prescription and for over-the-counter use.

Healgen EDDP (Methadone Metabolite) Test is an immunochromatographic assay for the qualitative determination of EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) in human urine at a Cut-Off concentration of $3 0 0 ~ \mathrm { { n g / m L } }$ . The test is available in a Strip format, a Cassette format, a Dip Card format and a Cup format.

The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive. For in vitro diagnostic use only. It is intended for prescription and for over-thecounter use.

# 3. Special conditions for use statement(s):

For over the counter (OTC) and prescription use.

4. Special instrument requirements:

Not applicable. The device is a visually read single-use device.

# I. Device Description:

Healgen Propoxyphene Test, Healgen Nortriptyline Test and Healgen EDDP Test are immunochromatographic assays for Propoxyphene, Nortriptyline and EDDP. Each assay test is a lateral flow system for the qualitative detection of Propoxyphene, Nortriptyline and EDDP (target analyte) in human urine. The products are in vitro diagnostic devices, which come in the form of: Strips, Cassettes, DipCards, or Cups. Each product contains a Test Device (in one of the four formats), and a package insert. Each test device is sealed with a desiccant in an aluminum pouch. The test is intended for use as the first step in a two-step process to provide consumers with information concerning the presence or absence of the above stated drugs in a urine sample. Information regarding confirmatory testing – the second step in the process is provided in the instructions for use.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Co-Innovation Biotech One Step Single/Multi drug Test

2. Predicate 510(k) number(s): k140748

3. Comparison with predicate:

<table><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Healgen Propoxyphene Test(Candidate Device)</td><td colspan="1" rowspan="1">k140748</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">For the qualitativedetermination ofPropoxyphene in humanurine.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Drug Analyte</td><td colspan="1" rowspan="1">Propoxyphene</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">Competitive binding, lateralflow immunochromatographicassays based on the principleof antigen antibodyimmunochemistry.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Cutoff Values</td><td colspan="1" rowspan="1">300 ng/mL</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Intended UsePopulation</td><td colspan="1" rowspan="1">For over-the-counter andprescription uses.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Healgen Propoxyphene Test(CandidateDevice)</td><td colspan="1" rowspan="1">k140748</td></tr><tr><td colspan="1" rowspan="1">Configuration</td><td colspan="1" rowspan="1">Strip, Cassette, Dip Card, Cup</td><td colspan="1" rowspan="1">Cup</td></tr><tr><td colspan="1" rowspan="1">Type of Test</td><td colspan="1" rowspan="1">Qualitative</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Human urine</td><td colspan="1" rowspan="1">Same</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Healgen Nortriptyline Test(Candidate Device)</td><td rowspan=1 colspan=1>k140748</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For the qualitativedetermination ofNortriptyline in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Drug Analyte</td><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateralflow immunochromatographicassays based on the principleof antigen antibodyimmunochemistry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cutoff Values</td><td rowspan=1 colspan=1>1000 ng/mL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Intended UsePopulation</td><td rowspan=1 colspan=1>For over-the-counter andprescription uses.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Configuration</td><td rowspan=1 colspan=1>Strip, Cassette, Dip Card, Cup</td><td rowspan=1 colspan=1>Cup</td></tr><tr><td rowspan=1 colspan=1>Type of Test</td><td rowspan=1 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human urine</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Healgen EDDP Test(Candidate Device)</td><td rowspan=1 colspan=1>k140748</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For the qualitativedetermination of EDDPin human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Drug Analyte</td><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateralflow immunochromatographicassays based on the principleof antigen antibodyimmunochemistry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cutoff Values</td><td rowspan=1 colspan=1>300 ng/mL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Intended UsePopulation</td><td rowspan=1 colspan=1>For over-the-counter andprescription uses.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Configuration</td><td rowspan=1 colspan=1>Strip, Cassette, Dip Card, Cup</td><td rowspan=1 colspan=1>Cup</td></tr><tr><td rowspan=1 colspan=1>Type of Test</td><td rowspan=1 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human urine</td><td rowspan=1 colspan=1>Same</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

None referenced.

# L. Test Principle:

Healgen Propoxyphene Test, Healgen Nortriptyline Test and Healgen EDDP Test are rapid tests for the qualitative detection of Propoxyphene, Nortriptyline and EDDP in urine samples. Each assay test is a lateral flow chromatographic immunoassay. Each assay uses a monoclonal anti-mouse antibody -dye conjugate against the drugs containing gold chloride and fixed drug-protein conjugates and anti-mouse IgG polyclonal antibody in the test membranes.

When the absorbent end of the test is immersed into the urine specimen, the urine is absorbed into the device by capillary action, mixes with the antibody-dye conjugate, and flows across the pre-coated membrane. When sample drug levels are zero or below the target Cut-Off, antibody-dye conjugate binds to the drug-protein conjugate immobilized in the Test Region (T) of the device. This produces a colored Test line that, regardless of its intensity, indicates a negative result.

When sample drug levels are at or above the target Cut-Off, the free drug in the sample binds to the antibody-dye conjugate preventing the antibody-dye conjugate from binding to the drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.

To serve as a procedure control, a colored line will appear at the Control Region (C), if the test has been performed properly because of the antibody-dye conjugate binding to antimouse IgG immobilized in the Control Region(C) of the device.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

The precision performance of the Healgen Propoxyphene Test, Healgen Nortriptyline Test and Healgen EDDP was evaluated using 3 lots for each format (Strip, Cassette, Cup, Dip Card) of the device by three operators. For each concentration, tests were performed two runs per day for 25 days by three different operators for each format of devices. The testing consisted of analyzing samples in 2 runs per day for 25 days $[ \mathfrak { n } = 5 0$ per lot) and by spiking drug free urine samples to achieve $100 \%$ cut off, $- 7 5 \%$ cut off, $- 5 0 \%$ cut off, $- 2 5 \%$ cut off, $+ 2 5 \%$ cut off, $+ 5 0 \%$ cut off , $+ 7 5 \%$ cut off and $+ 1 0 0 \%$ cut off drug concentrations. Each drug concentration was confirmed by GC/MS. Results are summarized below for each lot and device.

# Propoxyphene

Strip Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Cassette Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Dip Card Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>29-/21+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

CUP Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>29-/21+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Nortriptyline Strip Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Cassette Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>18-/32+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Dip Card Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>18-/32+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

CUP Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

EDDP Strip Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Cassette Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Dip Card Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

CUP Format   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%Cut-off</td><td rowspan=1 colspan=1>-75%Cut-off</td><td rowspan=1 colspan=1>-50%Cut-off</td><td rowspan=1 colspan=1>-25%Cut-off</td><td rowspan=1 colspan=1>Cut-off</td><td rowspan=1 colspan=1>+25%Cut-off</td><td rowspan=1 colspan=1>+50%Cut-off</td><td rowspan=1 colspan=1>+75%Cut-off</td><td rowspan=1 colspan=1>+100%Cut-off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>29-/21+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>18-/32+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

b. Linearity/assay reportable range:

Not applicable.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

External control materials are not supplied with the devices; however, the package inserts list information on how to obtain control materials.

Stability protocols and acceptance criteria of all test formats were reviewed and deemed acceptable. The shelf life stability information supports the claimed shelf life of 24 months at 4 to $3 0 ~ ^ { \circ } \mathrm { C }$ .

d. Detection limit: Not applicable.

# e. Analytical specificity:

Cross-reactivity was evaluated by spiking various concentrations of similarly structured drug compounds into drug-free urine. Samples were tested using three lots of each device for all formats. Results are expressed as a minimum concentration of metabolite or compound required to produce a response approximately equivalent to the cutoff concentration of the assay. The percent cross-reactivity of those compounds is listed below:

<table><tr><td rowspan=1 colspan=1>Propoxyphene(Cut-off=300 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>% Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Propoxyphene</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Norpropoxyphene</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Nortriptyline(Cut-off=1000 ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">Positive at 1000 ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">Positive at 1500 ng/mL</td><td colspan="1" rowspan="1">67%</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Positive at 50000 ng/mL</td><td colspan="1" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">Positive at 5000 ng/mL</td><td colspan="1" rowspan="1">20%</td></tr><tr><td colspan="1" rowspan="1">Doxepine</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Positive at 100000 ng/mL</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">Nordoxepin</td><td colspan="1" rowspan="1">Positive at 10000 ng/mL</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">Promazine</td><td colspan="1" rowspan="1">Positive at 50000 ng/mL</td><td colspan="1" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">Promethazine</td><td colspan="1" rowspan="1">Positive at 2500 ng/mL</td><td colspan="1" rowspan="1">40%</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">Positive at 50000 ng/mL</td><td colspan="1" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine Hydrochloride</td><td colspan="1" rowspan="1">Positive at 5000 ng/mL</td><td colspan="1" rowspan="1">20%</td></tr><tr><td colspan="1" rowspan="1">Norclomipramine</td><td colspan="1" rowspan="1">Positive at 50000 ng/mL</td><td colspan="1" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">EDDP(Cut-off=300 ng/mL)</td><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="1">EDDP(2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine)</td><td colspan="1" rowspan="1">Positive at300ng/mL</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">EMDP(2-Ethyl-5-methyl-3,3- diphenylpyrroline)</td><td colspan="1" rowspan="1">Positive at500 ng/mL</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Disopyramide</td><td colspan="1" rowspan="1">Positive at50000 ng/mL</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Negative at100000 ng/mL</td><td colspan="1" rowspan="1">&lt;0.3%</td></tr><tr><td colspan="1" rowspan="1">LAAM (Levo-alpha-acetylmethadol) HCl</td><td colspan="1" rowspan="1">Negative at100000 ng/mL</td><td colspan="1" rowspan="1">&lt;0.3%</td></tr><tr><td colspan="1" rowspan="1">Alpha Methadol</td><td colspan="1" rowspan="1">Negative at100000 ng/mL</td><td colspan="1" rowspan="1">&lt;0.3%</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Negative at100000 ng/mL</td><td colspan="1" rowspan="1">&lt;0.3%</td></tr></table>

Interference studies were performed using $1 0 0 ~ \mu \mathrm { g / m L }$ of commonly administered or OTC compounds (endogenous compounds, drugs, drug metabolites) that are commonly found in urine. These compounds were tested in urine containing $\pm 2 5 \%$ cutoff concentration for each analyte using three lots of each device for all formats. The following compounds were found not to interfere when tested at $1 0 0 ~ \mu \mathrm { g / m L }$ concentration.

Propoxyphene   

<table><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Ethyl-p-aminobenzoate</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic Acid(Aspirin)</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Phenylephrine-L</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">(+/-)-4-HydroxyamphetamineHCL</td><td colspan="1" rowspan="1">Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">D-Amphetamine</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">L-Amphetamine</td><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">Prednisolone Acetate</td></tr><tr><td colspan="1" rowspan="1">Amphetamine Sulfate</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Ampicinine(Ampicillin)</td><td colspan="1" rowspan="1">a-Hydroxyhippuric acid</td><td colspan="1" rowspan="1">Procaine(Novocaine)</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td><td colspan="1" rowspan="1">Promazine</td></tr><tr><td colspan="1" rowspan="1">L-Ascorbic Acid</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Propranolol</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Pseudoephedrine HCL</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Isoproterenol-(+/-)</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Benzoic Acid</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Ranitidine(Zantac)</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">Salicylic Acid</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Serotonin</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide HCL</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Chloroquine</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Temazepam</td></tr><tr><td colspan="1" rowspan="1">Chlorpheniramine</td><td colspan="1" rowspan="1">(+/-)Methylenedioxyamphetamine(MDA)</td><td colspan="1" rowspan="1">11-Nor-∆9-Tetrahydrocannabinol</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Nalbuphine</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Clonidine hydrochloride</td><td colspan="1" rowspan="1">Naloxone hydrochloride</td><td colspan="1" rowspan="1">L-Thyroxine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Naltrexone hydrochloride</td><td colspan="1" rowspan="1">Thioridazine Hydrochloride</td></tr><tr><td colspan="1" rowspan="1">Cotinine(-)</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">TriflupromazineHydrochloride</td></tr><tr><td colspan="1" rowspan="1">Deoxyepinephrine</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Trimipramine</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">DL-Tryptophan</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Oxymetazoline</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Papaverine</td><td colspan="1" rowspan="1">D/L-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">Ecgonine methylester</td><td colspan="1" rowspan="1">Penicillin</td><td colspan="1" rowspan="1">Uric Acid</td></tr><tr><td colspan="1" rowspan="1">R(-)-Epinephrine</td><td colspan="1" rowspan="1">Pentobarbital</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Perphenazine</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">Estrone-3-sulfate</td><td colspan="1" rowspan="1">Phencyclidine</td><td colspan="1" rowspan="1"></td></tr></table>

# Nortriptyline

<table><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Ethyl-p-aminobenzoate</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic Acid(Aspirin)</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phenylephrine-L</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">D-Amphetamine</td><td colspan="1" rowspan="1">(+/-)-4-HydroxyamphetamineHCL</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">L-Amphetamine</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">Prednisolone Acetate</td></tr><tr><td colspan="1" rowspan="1">Amphetamine Sulfate</td><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Ampicinine(Ampicillin)</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Procaine(Novocaine)</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">a-Hydroxyhippuric acid</td><td colspan="1" rowspan="1">Propoxyphene,d-</td></tr><tr><td colspan="1" rowspan="1">L-Ascorbic Acid</td><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td><td colspan="1" rowspan="1">Propranolol</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Pseudoephedrine HCL</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Isoproterenol-(+/-)</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Ranitidine(Zantac)</td></tr><tr><td colspan="1" rowspan="1">Bezoic Acid</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Salicylic Acid</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Serotonin</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide HCL</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Chloroquine</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Temazepam</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">(+/-)Methylenedioxyamphetamine(MDA)</td><td colspan="1" rowspan="1">11-Nor-Δ9-Tetrahydrocannabinol</td></tr><tr><td colspan="1" rowspan="1">Chlorpheniramine</td><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Nalbuphine</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Clonidine hydrochloride</td><td colspan="1" rowspan="1">Naloxone hydrochloride</td><td colspan="1" rowspan="1">L-Thyroxine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Naltrexone hydrochloride</td><td colspan="1" rowspan="1">ThioridazineHydrochloride</td></tr><tr><td colspan="1" rowspan="1">Cotinine(-)</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">TriflupromazineHydrochloride</td></tr><tr><td colspan="1" rowspan="1">Deoxyepinephrine</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">Norpropoxyphene</td><td colspan="1" rowspan="1">DL-Tryptophan</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">D/L-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Oxymetazoline</td><td colspan="1" rowspan="1">Uric Acid</td></tr><tr><td colspan="1" rowspan="1">Ecgonine methylester</td><td colspan="1" rowspan="1">Papaverine</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">R(-)-Epinephrine</td><td colspan="1" rowspan="1">Penicillin</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Pentobarbital</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Estrone-3-sulfate</td><td colspan="1" rowspan="1">Perphenazine</td><td colspan="1" rowspan="1"></td></tr></table>

EDDP   

<table><tr><td colspan="3" rowspan="1">DD</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Ethyl-p-aminobenzoate</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic Acid(Aspirin)</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phenylephrine-L</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">(+/-)-4-Hydroxyamphetamine HCLPhenylpropanolamine</td><td colspan="1" rowspan="1">cYanmaentaYellow</td></tr><tr><td colspan="1" rowspan="1">D-Amphetamine</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">Prednisolone Acetate</td></tr><tr><td colspan="1" rowspan="1">L-Amphetamine</td><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Amphetamine Sulfate</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Procaine(Novocaine)</td></tr><tr><td colspan="1" rowspan="1">Ampicinine(Ampicillin)</td><td colspan="1" rowspan="1">a-Hydroxyhippuric acid</td><td colspan="1" rowspan="1">Promazine</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">L-Ascorbic Acid</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Propoxyphene,d-</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Propranolol</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Pseudoephedrine HCL</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Isoproterenol-(+/-)</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Bezoic Acid</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Ranitidine(Zantac)</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">Salicylic Acid</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Serotonin</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide   HCL</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Chloroquine</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Temazepam</td></tr><tr><td colspan="1" rowspan="1">Chlorpheniramine</td><td colspan="1" rowspan="1">(+/-)-MethylenedioxyamphetamineMDA)</td><td colspan="1" rowspan="1">11-Nor-Δ9-Tetrahydrocannabinol</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Nalbuphine</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Clonidine hydrochloride</td><td colspan="1" rowspan="1">Naloxone hydrochloride</td><td colspan="1" rowspan="1">L-Thyroxine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Naltrexone hydrochloride</td><td colspan="1" rowspan="1">Thioridazine Hydrochloride</td></tr><tr><td colspan="1" rowspan="1">Cotinine(-)</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">TriflupromazineHydrochloride</td></tr><tr><td colspan="1" rowspan="1">Deoxyepinephrine</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Trimipramine</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">Norpropoxyphene</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">DL-Tryptophan</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Oxymetazoline</td><td colspan="1" rowspan="1">D/L-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">Ecgonine methylester</td><td colspan="1" rowspan="1">Papaverine</td><td colspan="1" rowspan="1">Uric Acid</td></tr><tr><td colspan="1" rowspan="1">R(-)-Epinephrine</td><td colspan="1" rowspan="1">Penicillin</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Pentobarbital</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">Estrone-3-sulfate</td><td colspan="1" rowspan="1">Perphenazine</td><td colspan="1" rowspan="1"></td></tr></table>

Specific Gravity and $\mathsf { p H }$ studies:

Twelve urine samples with specific gravity ranges (1.000-1.035) were collected and spiked with each drug at $2 5 \%$ below and $2 5 \%$ above cutoff levels. Each sample was tested using three lots of each format of the test devices. The results showed that a specific gravity range of 1.000 to 1.035 does not affect the accuracy of the tests.

A negative urine pool was adjusted to a $\mathsf { p H }$ range of 4.00 to 9.00 in $1 \mu \mathrm { H }$ unit increments and was spiked with each drug at $2 5 \%$ below and $2 5 \%$ above cutoff levels. Samples were tested using three lots of each format of the devices, and results showed that urine $\mathrm { p H }$ range of 4.00 to 9.00 does not affect the accuracy of the tests.

# f. Assay cut-off:

The characterization of how the device performs analytically around the claimed cutoff concentration of $3 0 0 ~ \mathrm { { n g / m L } }$ Propoxyphene, $1 0 0 0 ~ \mathrm { { n g / m L } }$ Nortriptyline, and 300 $\mathrm { n g / m L }$ EDDP is described in the precision section, M.1.a. above.

# a. Method comparison with predicate device:

The method comparison for the Healgen Propoxyphene Test, Healgen Nortriptyline Test and Healgen EDDP Test was performed internally against the reference method, GC/MS. Operators ran 80 unaltered urine samples on each format of the devices, where each device format was tested by an independent set of three operators. The samples were masked and randomized prior to testing and device results were compared to GC/MS. The results are presented in the table below:

Propoxyphene   

<table><tr><td rowspan=1 colspan=1>Stripformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Propoxyphene Strip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Cassetteformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Propoxyphene Cassette   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Cassette FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Cupformat</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Propoxyphene Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Cup FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=2 colspan=1>Dip Cardformat</td><td rowspan=2 colspan=1>b</td><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>LowNegative byGC/MS(less than-50%</td><td rowspan=2 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS</td><td rowspan=1 colspan=1>HighPositive byGC/MS</td></tr><tr><td rowspan=1 colspan=1>(Between thecut-offand +50%)</td><td rowspan=1 colspan=1>(greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Propoxyphene Dip Card   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Dip Card FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX67</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX66</td><td rowspan=1 colspan=1>304</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Nortriptyline   

<table><tr><td rowspan=2 colspan=1>Stripformat</td><td rowspan=2 colspan=1>b</td><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=2 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS</td><td rowspan=2 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=1 colspan=1>(Betweenthe cut-offand +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Nortriptyline Strip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCA27</td><td rowspan=1 colspan=1>1011</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCA27</td><td rowspan=1 colspan=1>1011</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA27</td><td rowspan=1 colspan=1>1011</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=2 colspan=1>Cassetteformat</td><td rowspan=2 colspan=1>b</td><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=2 colspan=2>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=2 colspan=2>Near CutoffPositive byGC/MS(Between thecut-offand +50%)</td><td rowspan=2 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>GC/MS</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>0</td><td rowspan=1 colspan=2>13</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>15</td><td rowspan=1 colspan=2>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>0</td><td rowspan=1 colspan=2>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>15</td><td rowspan=1 colspan=2>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>0</td><td rowspan=1 colspan=2>13</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>15</td><td rowspan=1 colspan=2>3</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Nortriptyline Cassette   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Cassette FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCA34</td><td rowspan=1 colspan=1>1232</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCA52</td><td rowspan=1 colspan=1>1123</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCA34</td><td rowspan=1 colspan=1>1232</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA34</td><td rowspan=1 colspan=1>1232</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA52</td><td rowspan=1 colspan=1>1123</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=3 colspan=1>Dip Cardformat</td><td rowspan=3 colspan=1>b</td><td rowspan=3 colspan=1>Negative</td><td rowspan=3 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=3 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=2 colspan=2>Near CutoffPositive byGC/MS</td><td rowspan=3 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=2>(Betweenthe cut-offand +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Nortriptyline Dip Card   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Dip Card FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCA27</td><td rowspan=1 colspan=1>1011</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCA27</td><td rowspan=1 colspan=1>1011</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA27</td><td rowspan=1 colspan=1>1011</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=2 colspan=1>Cupformat</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>LowNegativeby GC/MS(less than-50%</td><td rowspan=2 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS</td><td rowspan=2 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=1 colspan=1>(Betweenthe cut-offand +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Nortriptyline Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Cup FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCA27</td><td rowspan=1 colspan=1>1011</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TCA38</td><td rowspan=1 colspan=1>1097</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCA27</td><td rowspan=1 colspan=1>1011</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>TCA38</td><td rowspan=1 colspan=1>1097</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA51</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA27</td><td rowspan=1 colspan=1>1011</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TCA38</td><td rowspan=1 colspan=1>1097</td><td rowspan=1 colspan=1>Negative</td></tr></table>

EDDP   

<table><tr><td rowspan=4 colspan=1>Stripformat</td><td rowspan=4 colspan=1>b</td><td rowspan=4 colspan=1>Negative</td><td rowspan=4 colspan=1>LowNegativeby GC/MS(less than-50%)</td><td rowspan=4 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=3 colspan=2>Near CutoffPositive byGC/MS</td><td rowspan=4 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=2>(Betweenthe cut-offand +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>13</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>13</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>3</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of EDDP Strip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Strip FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP28</td><td rowspan=1 colspan=1>308</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDP28</td><td rowspan=1 colspan=1>308</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=6 colspan=1>Cassetteformat</td><td rowspan=6 colspan=1>b</td><td rowspan=6 colspan=1>Negative</td><td rowspan=1 colspan=1>Low</td><td rowspan=1 colspan=2>Near Cutoff</td><td rowspan=1 colspan=3>Near Cutoff</td><td rowspan=5 colspan=1>HighPositive byGC/MS</td></tr><tr><td rowspan=5 colspan=1>Negativeby GC/MS(less than-50%)</td><td rowspan=5 colspan=2>Negative byGC/MS(Between-50% andcut-off)</td><td rowspan=3 colspan=2>Pos</td><td></td></tr><tr><td rowspan=1 colspan=2>Pos</td><td></td></tr><tr><td rowspan=1 colspan=2>Positive by</td></tr><tr><td rowspan=1 colspan=3>GC/MS</td></tr><tr><td rowspan=1 colspan=3>(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>(greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>0</td><td rowspan=1 colspan=3>13</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>15</td><td rowspan=1 colspan=3>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>0</td><td rowspan=1 colspan=3>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>15</td><td rowspan=1 colspan=3>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=2>0</td><td rowspan=1 colspan=3>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=2>15</td><td rowspan=1 colspan=3>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of EDDP Cassette   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Cassette FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP28</td><td rowspan=1 colspan=1>308</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=3 colspan=1>Dip Cardformat</td><td rowspan=3 colspan=1></td><td rowspan=3 colspan=1>Negative</td><td rowspan=3 colspan=1>LowNegativeby GC/MS(less than-50%)</td><td rowspan=3 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive by</td><td rowspan=3 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=1 colspan=1>GC/MS</td></tr><tr><td rowspan=1 colspan=1>(Betweenthe cut-offand +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of EDDP Dip Card   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Dip Card FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDP28</td><td rowspan=1 colspan=1>308</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Cupformat</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby GC/MS(less than-50%</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcut-off)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Betweenthe cut-offand +50%)</td><td rowspan=1 colspan=1>HighPositive byGC/MS(greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of EDDP Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Cup FormatViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDP02</td><td rowspan=1 colspan=1>302</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>EDDP72</td><td rowspan=1 colspan=1>303</td><td rowspan=1 colspan=1>Negative</td></tr></table>

b. Matrix comparison: Not applicable. The assays are intended to be used with urine samples only.

3. Clinical studies:

a. Clinical Sensitivity: Not applicable.

b. Clinical specificity: Not applicable.

c. Other clinical supportive data (when a. and b. are not applicable):

A lay user study was performed at three intended user sites with 560 lay persons testing each of the Propoxyphene, the Nortriptyline and the EDDP devices. Total of 1680 individuals performed the study. A total of 204 females and 356 males tested the Propoxyphene samples, 213 females and 347 males tested the Nortriptyline samples and 209 females and 351 males tested the EDDP samples. They had diverse educational and professional backgrounds and ranged in age from 21 to $> 5 0$ years. Urine samples were prepared at the following concentrations; negative, $+ / - 7 5 \%$ , $+ / - 5 0 \%$ , $+ / - 2 5 \%$ of the cutoff by spiking drugs into drug free-pooled urine specimens. The concentrations of the samples were confirmed by GC/MS. Each sample was aliquoted into individual containers and blind-labeled. Each participant was provided with the package insert, 1 blind labeled sample and a device. The results are summarized below.

Comparison between GC/MS and Lay Person Results (Propoxyphene Strip)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>PropoxypheneConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (Propoxyphene Cassette)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>PropoxypheneConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (Propoxyphene DipCard)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>PropoxypheneConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (Propoxyphene Cup)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>PropoxypheneConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (Nortriptyline Strip)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>NortriptylineConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (Nortriptyline Cassette)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>NortriptylineConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (Nortriptyline DipCard)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>NortriptylineConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (Nortriptyline Cup)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>NortriptylineConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (EDDP Strip)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>EDDPConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (EDDP Cassette)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>EDDPConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (EDDP Dipcard)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>EDDPConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Comparison between GC/MS and Lay Person Results (EDDP Cup)   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>EDDPConcentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

The labeling is rated at 7th grade reading level per Flesch-Kincaid Methodology. All participants $( 1 0 0 \% )$ indicated on the questionnaire that the labeling instructions were clear or very clear and that they did not find the tests difficult to operate.

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range: Not applicable.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.